Faraz A. Choudhury, PhD profile page

Dr. Faraz A. Choudhury is the co-founder and CEO of Immuto Scientific, a biotechnology company working on structural surfaceomics to transform how new drug targets and therapeutics are discovered. Since founding the company in 2018, Choudhury has defined Immuto’s scientific vision and commercial strategy, leading its evolution from an academic concept into a venture-backed innovator at the intersection of proteomics, structural biology and AI. Under his leadership, Immuto has secured partnerships with several top global pharmaceutical companies, validating its technology and accelerating its translation into real-world drug discovery programs. He co-invented Immuto’s initial core technology and has guided its development into a high-throughput structural proteomics platform capable of mapping protein conformations directly in living cells and patient samples. Prior to founding Immuto, Choudhury served as a research scientist in the Department of Biochemistry at the University of Wisconsin–Madison, where he applied advanced mass spectrometry to study protein structures and interactions. He earned his PhD in electrical engineering and a graduate certificate in entrepreneurship from UW–Madison, where his doctoral research focused on plasma technologies for both semiconductor and biological applications. Choudhury is the author of multiple peer-reviewed publications and patents and is recognized for advancing a new frontier in structure-based drug discovery.